|
|
||||||||
CUTTING EDGE |







* Basic Research Laboratory,
Laboratory of Comparative Carcinogenesis, and
Laboratory of Molecular Immunoregulation, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702;
Basic Research Program, SAIC-Frederick, Frederick, MD 21702; and
¶
Vanderbilt University Medical Center, Nashville, TN 37232
Drm/Gremlin and Dan, two homologous secreted antagonists of bone morphogenic proteins, have been shown to regulate early development, tumorigenesis, and renal pathophysiology. In this study, we report that Drm and Dan physically and functionally interact with Slit1 and Slit2 proteins. Drm binding to Slits depends on its glycosylation and is not interfered with by bone morphogenic proteins. Importantly, Drm and Dan function as inhibitors for monocyte migration induced by stromal cell-derived factor 1
(SDF-1
) or fMLP. The inhibition of SDF-1
-induced monocyte chemotaxis by Dan is not due to blocking the binding of SDF-1
to its receptor. Thus, the results identify that Drm and Dan can interact with Slit proteins and act as inhibitors of monocyte chemotaxis, demonstrating a previously unidentified biological role for these proteins.
This article has been cited by other articles:
![]() |
R. E. Dickinson, M. Myers, and W. C. Duncan Novel Regulated Expression of the SLIT/ROBO Pathway in the Ovary: Possible Role during Luteolysis in Women Endocrinology, October 1, 2008; 149(10): 5024 - 5034. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Keizer-Gunnink, A. Kortholt, and P. J.M. Van Haastert Chemoattractants and chemorepellents act by inducing opposite polarity in phospholipase C and PI3-kinase signaling J. Cell Biol., May 21, 2007; 177(4): 579 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Stabile, S. Mitola, E. Moroni, M. Belleri, S. Nicoli, D. Coltrini, F. Peri, A. Pessi, L. Orsatti, F. Talamo, et al. Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor Blood, March 1, 2007; 109(5): 1834 - 1840. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Cavanna, E. Pokorna, P. Vesely, C. Gray, and D. Zicha Evidence for protein 4.1B acting as a metastasis suppressor J. Cell Sci., February 15, 2007; 120(4): 606 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Koli, M. Myllarniemi, K. Vuorinen, K. Salmenkivi, M. J. Ryynanen, V. L. Kinnula, and J. Keski-Oja Bone Morphogenetic Protein-4 Inhibitor Gremlin Is Overexpressed in Idiopathic Pulmonary Fibrosis Am. J. Pathol., July 1, 2006; 169(1): 61 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Ly, K. Komatsuzaki, I. P. Fraser, A. A. Tseng, P. Prodhan, K. J. Moore, and T. B. Kinane Netrin-1 inhibits leukocyte migration in vitro and in vivo PNAS, October 11, 2005; 102(41): 14729 - 14734. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |